The US Bone & Joint Health Supplements Market was valued at USD 2,860 Million in 2025 and is expected to reach USD 6,340 Million by 2035, growing at a CAGR of 7.8% from 2024 to 2035.
The economic impact of tariffs on "US Bone & Joint Health Supplements Market".
Market Growth Drivers
Aging Population and Increasing Prevalence of Osteoporosis: The rising geriatric population in the US, projected to reach over 80 million by 2040 (US Census Bureau), has resulted in a significant surge in demand for bone and joint health supplements. Aging directly correlates with an increased risk of osteoporosis and related disorders, prompting consumers to seek preventive measures such as calcium and vitamin D supplements. Companies like Amway’s Nutrilite and Bayer’s Citracal have intensified their focus on marketing bone health products targeted at seniors, while also developing enhanced formulations to improve calcium absorption and overall bone strength.
Growing Awareness of Preventive Healthcare: The shift toward preventive healthcare, amplified by digital health campaigns and the COVID-19 pandemic, fosters the consistent growth of the US bone and joint supplements market. Consumers are increasingly taking proactive steps to maintain bone health before the onset of clinical problems. Leading companies such as Nature’s Bounty (The Bountiful Company) emphasize awareness campaigns and product innovation, introducing joint health blends with glucosamine, chondroitin, and turmeric, catered toward active adults and younger demographics.
Market Trends
Rise of Plant-Based and Vegan Supplements: There is a marked increase in consumer demand for plant-based, non-GMO, and vegan supplement options in the US. Companies such as Garden of Life and VeganVitality have responded by launching a variety of bone and joint health supplements made from algae-based calcium and botanical sources of vitamin D3. This trend is further propelled by the growing population of health-conscious individuals seeking clean label, allergen-free products.
Integration of Technology and Personalized Nutrition: The use of technology to provide personalized nutrition plans is shaping the supplement industry. Organizations like Persona Nutrition (Nestlé Health Science) utilize AI and health data analytics to offer tailored supplement recommendations, including specific bone and joint health formulations. This not only drives consumer engagement but also improves efficacy, leading to better health outcomes and increased brand loyalty.
Market Opportunity
Expansion into E-Commerce and Direct-to-Consumer Channels: Online sales channels present an untapped growth opportunity for US bone and joint health supplement brands. Companies such as HUM Nutrition and Ritual are leveraging digital platforms to reach younger consumers through subscription models and influencer marketing.
Product Innovation in Joint Support for Sports and Fitness: With an increasing number of consumers engaging in fitness activities, there is substantial potential for functional joint support supplements aimed at athletes and active adults. Companies like Schiff Nutrition (Reckitt Benckiser) are developing advanced formulations containing collagen peptides and MSM to cater to this segment.
US Bone & Joint Health Supplements Market Revenue (USD Million), 2020-2035
The market shows a strong, steady uptick in revenue from USD 1,750 Million in 2020 to an expected USD 6,340 Million by 2035. Driven by an aging population, increased preventative health awareness, and product innovation, the CAGR is anticipated to be 7.8% during the forecast period. Growth accelerates especially after 2025, paralleling the adoption of online purchase models and the introduction of targeted supplements. This upward trajectory indicates a healthy market outlook, with new entrants and product diversification spurring further increments in value.
US Bone & Joint Health Supplements Market by Region, 2025
In 2025, the regional market share is led by the South (31%) due to higher elderly populations and chronic disease prevalence. The Midwest (25%) and the West (23%) follow closely, with robust health supplement adoption and distribution networks. The Northeast (17%) market benefits from higher disposable income and urban health trends, while the Others category (4%) includes outlying states and territories with lower penetration. This distribution highlights the importance of tailoring marketing and distribution strategies to each region’s demographic and health trends.
Recent Market Developments (Last 6 Months)
In March 2024, Nature’s Bounty (The Bountiful Company) announced the launch of an advanced plant-based bone & joint health supplement range. Leveraging algae-sourced calcium and vegan-friendly vitamin D3, the products target environmentally conscious consumers and those with dietary restrictions. Initial launch channels include major e-retailers and select US pharmacies.
Persona Nutrition (Nestlé Health Science) partnered with Walgreens in April 2024 to expand their personalized nutrition platform, allowing consumers to access tailored bone and joint supplement solutions in-store. This collaboration aims to enhance the retail experience by integrating digital health assessments and on-the-spot product recommendations.
In May 2024, Schiff Nutrition (Reckitt Benckiser) introduced MoveFree Ultra Advanced, a joint health supplement formulated with collagen peptides and curcumin. This formulation responds to growing demand among fitness enthusiasts and aging consumers for highly bioavailable joint support ingredients. The company reported positive initial sales trends across leading e-commerce platforms.
Press Releases